Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-trace').style.display = (document.getElementById('cakeErr67f985f2db448-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f985f2db448-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-code').style.display = (document.getElementById('cakeErr67f985f2db448-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-context').style.display = (document.getElementById('cakeErr67f985f2db448-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f985f2db448-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f985f2db448-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6093,
		&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6187,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6093,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6093,
	&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6187,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6093
$metaTitle = &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew | Im4change.org</title>
    <meta name="description" content="
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br /><br />For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br /><br />So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br /><br />According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br /><br />Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br /><br />According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br /><br />Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br /><br />India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br /><br />EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-trace').style.display = (document.getElementById('cakeErr67f985f2db448-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f985f2db448-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-code').style.display = (document.getElementById('cakeErr67f985f2db448-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-context').style.display = (document.getElementById('cakeErr67f985f2db448-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f985f2db448-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f985f2db448-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6093,
		&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6187,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6093,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6093,
	&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6187,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6093
$metaTitle = &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew | Im4change.org</title>
    <meta name="description" content="
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br /><br />For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br /><br />So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br /><br />According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br /><br />Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br /><br />According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br /><br />Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br /><br />India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br /><br />EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-trace').style.display = (document.getElementById('cakeErr67f985f2db448-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f985f2db448-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-code').style.display = (document.getElementById('cakeErr67f985f2db448-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f985f2db448-context').style.display = (document.getElementById('cakeErr67f985f2db448-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f985f2db448-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f985f2db448-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 6093,
		&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 6187,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 6093,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 6093,
	&#039;title&#039; =&gt; &#039;India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;
&lt;br /&gt;
For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;
&lt;br /&gt;
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;
&lt;br /&gt;
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;
&lt;br /&gt;
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;
&lt;br /&gt;
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;
&lt;br /&gt;
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;
&lt;br /&gt;
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;
&lt;br /&gt;
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 6187,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 6093
$metaTitle = &#039;LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&amp;ndash;EU Free Trade Agreement (FTA) negotiations.&lt;br /&gt;&lt;br /&gt;For instance, EU negotiators have sought India&amp;rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.&lt;br /&gt;&lt;br /&gt;So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.&lt;br /&gt;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&amp;rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.&lt;br /&gt;&lt;br /&gt;According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &amp;ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&amp;rdquo; he said.&lt;br /&gt;&lt;br /&gt;Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.&lt;br /&gt;&lt;br /&gt;According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.&lt;br /&gt;&lt;br /&gt;Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.&lt;br /&gt;&lt;br /&gt;India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.&lt;br /&gt;&lt;br /&gt;EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew | Im4change.org</title>
    <meta name="description" content="
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br /><br />For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br /><br />So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br /><br />According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br /><br />Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br /><br />According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br /><br />Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br /><br />India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br /><br />EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 6093,
		'title' => 'India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew',
		'subheading' => '',
		'description' => '<div align="justify">
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br />
<br />
For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br />
<br />
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br />
<br />
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br />
<br />
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br />
<br />
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br />
<br />
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br />
<br />
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br />
<br />
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
</div>',
		'credit_writer' => 'The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 6187,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 6093,
	'metaTitle' => 'LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew',
	'metaKeywords' => 'Health',
	'metaDesc' => '
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...',
	'disp' => '<div align="justify">India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br /><br />For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br /><br />So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br /><br />According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br /><br />Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br /><br />According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br /><br />Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br /><br />India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br /><br />EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 6093,
	'title' => 'India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew',
	'subheading' => '',
	'description' => '<div align="justify">
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br />
<br />
For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br />
<br />
So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br />
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br />
<br />
According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br />
<br />
Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br />
<br />
According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br />
<br />
Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br />
<br />
India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br />
<br />
EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.
</div>',
	'credit_writer' => 'The Business Standard, 21 February, 2011, http://www.business-standard.com/india/news/india-eu-fta-tough-negotiations-over-healthcare-norms/425921/',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'india-eu-fta-tough-negotiations-over-healthcare-norms-by-joe-c-mathew-6187',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 6187,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 6093
$metaTitle = 'LATEST NEWS UPDATES | India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew'
$metaKeywords = 'Health'
$metaDesc = '
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.

For instance, EU negotiators have...'
$disp = '<div align="justify">India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India&ndash;EU Free Trade Agreement (FTA) negotiations.<br /><br />For instance, EU negotiators have sought India&rsquo;s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards.<br /><br />So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.<br /></div><div align="justify">&nbsp;</div><div align="justify">&ldquo;In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,&rdquo; said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry.<br /><br />According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. &ldquo;Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,&rdquo; he said.<br /><br />Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions.<br /><br />According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories.<br /><br />Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials.<br /><br />India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products.<br /><br />EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

India-EU FTA: Tough negotiations over healthcare norms by Joe C Mathew

India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India–EU Free Trade Agreement (FTA) negotiations. For instance, EU negotiators have sought India’s commitment to adopting Global Harmonization Task Force (GHTF) norms for medical devices. The move comes at a time when India and other Asian countries are trying to formulate their own harmonised regulatory guidelines for medical devices due to divergent views on some of the GHTF standards. So, too, with International Conference on Harmonization (ICH) guidelines for drug regulators, as India is trying to align its rules with most of the ICH standards, though not favouring a mere adoption.   “In-principle, India is working towards harmonising its standards with that of GHTF. But blind adoption of standards will only benefit global multinational medical device makers, not us,” said Rajiv Nath, co-ordinator of the Association of Indian Medical Devices Industry. According to Nath, labeling requirements under GHTF allow companies to outsource their products from any parts of the world, without differentiating between the countries of origin. “Our labeling rules are more stringent, as we require specific disclosures with regard to the country of origin. It prevents companies from sourcing their branded products from the cheapest destinations and turn Indian products less competitive,” he said. Similarly, EU wants Indian drug regulations to be in tune with ICH standards, though health ministry officials say a perfect alignment with ICH standards is not be possible under Indian conditions. According to sources, EU is also advocating a harmonised drug approval process, where both parties will rely on data from clinical trials, conducted in line with ICH guidelines, for the authorisation of medicinal products for human use in their markets and refrain from requiring specific clinical trials in their territories. Drug industry sources say strict adherence to ICH guidelines will help big pharmaceutical companies, but prove to be a barrier for the growth of smaller ones due to the cost involved in such trials. India is also expected to become a signatory to the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme for medicinal products. Jointly referred to as PIC/S, these are two international instruments between countries and pharmaceutical inspection authorities for the international development, implementation and maintenance of harmonised Good Manufacturing Practice standards and quality systems of inspectorates in the field of medicinal products. EU also wants India to ensure its laws, procedures and implementing guidelines, related to the regulation of medicinal products, medical devices and cosmetics, to be transparent and be framed after appropriate stakeholder consultation. Such participatory approach has been suggested even in the case of price fixation of products.